Prediction of type 1 diabetes

Diabetes

Volumn 62, Issue 4, 2013, Pages 1020-1021

  Erlich, Henry A ^a   Valdes, Ana M ^b   Noble, Janelle A ^c  

^a ROCHE MOLECULAR SYSTEMS   (United States)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; HLA A ANTIGEN; HLA A24 ANTIGEN; HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22;

GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HETEROZYGOTE; HLA SYSTEM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PREDICTION; PRIORITY JOURNAL;

AUTOANTIBODIES; DIABETES MELLITUS, TYPE 1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HLA-A24 ANTIGEN; HUMANS; MALE;

EID: 84875453617     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db12-1593     Document Type: Note

References (20)

1. Concannon P, Erlich HA, Julier C, et al.; Type 1 Diabetes Genetics Consortium. Type 1 diabetes: evidence for susceptibility loci from four genomewide linkage scans in 1,435 multiplex families. Diabetes 2005;54:2995-3001
2. Erlich H, Valdes AM, Noble J, et al.; Type 1 Diabetes Genetics Consortium. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the Type 1 Diabetes Genetics Consortium families. Diabetes 2008;57:1084-1092
3. Noble JA, Valdes AM, Varney MD, et al.; Type 1 Diabetes Genetics Consortium. HLA class I and genetic susceptibility to type 1 diabetes: results from the Type 1 Diabetes Genetics Consortium. Diabetes 2010;59:2972-2979
4. Varney MD, Valdes AM, Carlson JA, et al.; Type 1 Diabetes Genetics Consortium. HLA DPA1, DPB1 alleles and haplotypes contribute to the risk associated with type 1 diabetes: analysis of the Type 1 Diabetes Genetics Consortium families. Diabetes 2010;59:2055-2062
5. Howson JM, Walker NM, Clayton D, Todd JA, Type 1 Diabetes Genetics Consortium. Confirmation of HLA class II independent type 1 diabetes associations in the major histocompatibility complex including HLA-B and HLA-A. Diabetes Obes Metab 2009;11(Suppl. 1):31-45
6. Nejentsev S, Howson JM, Walker NM, et al.; Wellcome Trust Case Control Consortium. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 2007;450:887-892
7. Knip M, Siljander H. Autoimmune mechanisms in type 1 diabetes. Autoimmun Rev 2008;7:550-557
8. LaGasse JM, Brantley MS, Leech NJ, et al. Successful prospective prediction of type 1 diabetes in schoolchildren through multiple defined autoantibodies: an 8-year follow-up of the Washington State Diabetes Prediction Study. Diabetes Care 2002;25:505-511
9. Parikka V, Näntö-Salonen K, Saarinen M, et al. Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk. Diabetologia 2012; 55:1926-1936
10. Pietropaolo M, Towns R, Eisenbarth GS. Humoral autoimmunity in type 1 diabetes: prediction, significance, and detection of distinct disease subtypes. Cold Spring Harb Perspect Med. 2012;2:a012831
11. Barrett JC, Clayton DG, Concannon P, et al.; Type 1 Diabetes Genetics Consortium. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 2009;41:703-707
12. Aly TA, Ide A, Jahromi MM, et al. Extreme genetic risk for type 1A diabetes. Proc Natl Acad Sci USA 2006;103:14074-14079
13. Steck AK, Wong R, Wagner B, et al. Effects of non-HLA gene polymorphisms on development of islet autoimmunity and type 1 diabetes in a population with high-risk HLA-DR,DQ genotypes. Diabetes 2012;61:753-758
14. Xu P, Beam CA, Cuthbertson D, Sosenko JM, Skyler JS, Krischer JP, DPT-1 Study Group. Prognostic accuracy of immunologic and metabolic markers for type 1 diabetes in a high-risk population: receiver operating characteristic analysis. Diabetes Care 2012;35:1975-1980
15. Yu L, Boulware DC, Beam CA, et al.; Type 1 Diabetes TrialNet Study Group. Zinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical autoantibodies. Diabetes Care 2012;35:1213-1218
16. Barker JM, Barriga KJ, Yu L, et al.; Diabetes Autoimmunity Study in the Young. Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). J Clin Endocrinol Metab 2004;89:3896-3902
17. Mbunwe E, Van der Auwera BJ, Vermeulen I, et al. HLA-A*24 is an independent predictor of 5-year progression to diabetes in autoantibodypositive first-degree relatives of type 1 diabetic patients. Diabetes 2013;62: 1345-1350
18. Noble JA, Valdes AM, Bugawan TL, Apple RJ, Thomson G, Erlich HA. The HLA class I A locus affects susceptibility to type 1 diabetes. Hum Immunol 2002;63:657-664
19. Bugawan TL, Klitz W, Alejandrino M, et al. The association of specific HLA class I and II alleles with type 1 diabetes among Filipinos. Tissue Antigens 2002;59:452-469
20. Bossuyt P. Evidence-Based Laboratory Medicine: Principles, Practice, and Outcomes. Washington, DC, AACC Press, 2007, p. 67-81